2023-11-17 · Notice · 2023-25485
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Semaglutide
Open attributed record →Federal Register publication year
2023 FDA Federal Register peptide records
5 documents attributed to FDA and HHS and published in 2023, connected only through exact reviewed peptide-name matches.
2023-08-24 · Notice · 2023-18241
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Alternative Form of Hearing
Exenatide
Open attributed record →2023-08-24 · Notice · 2023-18250
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Exenatide
Open attributed record →2023-08-22 · Notice · 2023-18026
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Glucagon + Tirzepatide
Open attributed record →2023-02-17 · Notice · 2023-03364
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Afamelanotide + Glucagon + Leuprolide + Vosoritide
Open attributed record →